Correlation of whole blood hydroxychloroquine concentration with cutaneous lupus erythematosus and factors associated with it: first multicenter, cross-sectional analysis in Malaysia
Hydroxychloroquine (HCQ) is the first-line systemic treatment for cutaneous lupus erythematosus (CLE). Whole blood HCQ concentration (WBHCQ) was found to correlate with CLE severity among Caucasians. However, studies on Asians are scarce. We aim to explore the relationship of WBHCQ with CLE disease...
Saved in:
Main Authors: | Peh, D., Wan Ahmad Kammal, W. S. L., Beh, P. J., Yong, A. C. H., Tan, W. C., Lim, A. L., Thevarajah, S., Stanslas, J., How, Kang Nien |
---|---|
Format: | Article |
Published: |
Wiley-Blackwell Publishing
2022
|
Online Access: | http://psasir.upm.edu.my/id/eprint/100818/ https://onlinelibrary.wiley.com/doi/abs/10.1111/1346-8138.16292 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patterns of medication use in systemic lupus erythematosus: A multicenter cohort study
by: Kandane-Rathnayake, Rangi, et al.
Published: (2022) -
Systemic Lupus Erythematosus (SLE)
by: Anon
Published: (2010) -
Prevalence and clinical significance of antibodies to ribonucleoproteins in systemic lupus erythematosus in Malaysia.
by: Wang, C.L., et al.
Published: (1996) -
Hydroxychloroquine for COVID-19: a single center, retrospective cohort study
by: Wen, Chung Ho, et al.
Published: (2022) -
Genetic risk Factors of systemic lupus erythematosus in the Malaysian population: a minireview
by: Hwa Chia, C., et al.
Published: (2012)